Studying the Effect of Changing Immunosuppression in Case of Polyoma BK Virus Infection of the Renal Transplant (BKVIRUS)
Polyomavirus BK Nephropathy After Renal Transplantation: Randomized Clinical Trial to Demonstrate That Switching to mTOR Inhibitor is More Effective Than a Reduction of Immunosuppressive Therapy
Sponsor: Hannover Medical School
This PHASE4 trial investigates Disorder Related to Renal Transplantation and Immunosuppression Related Infectious Disease and is currently ongoing. Hannover Medical School leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Nov 2018 — Jan 2021 [monthly]
Unknown Status PHASE4
Status: Not Yet Recruiting → Unknown Status
▶ Show 1 earlier version
-
Jan 2017 — Nov 2018 [monthly]
Not Yet Recruiting PHASE4
First recorded
Oct 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hannover Medical School
For direct contact, visit the study record on ClinicalTrials.gov .